Pharmavite LLC Sustainability Profile
Pharmavite LLC, a leading name in the dietary supplement industry, is headquartered in the United States. Founded in 1971, the company has established itself as a pioneer in the development of high-quality vitamins and supplements, with a strong focus on innovation and consumer health. With major operational regions across North America, Pharmavite is renowned for its flagship brands, including Nature Made and MegaFood, which are distinguished by their commitment to quality and efficacy. The company’s unique approach to product formulation, emphasising natural ingredients and rigorous testing, sets it apart in a competitive market. Pharmavite's dedication to sustainability and health has earned it a prominent position within the industry, making it a trusted choice for consumers seeking reliable nutritional support.
DitchCarbon Score
How does Pharmavite LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmavite LLC's score of 56 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmavite LLC, headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of Otsuka Pharmaceutical Co., Ltd., which influences its climate commitments and initiatives. Pharmavite's climate strategy is aligned with the broader goals set by its parent company, Otsuka Holdings Co., Ltd. While specific reduction targets from Pharmavite are not detailed, the overarching commitments from Otsuka include initiatives under the Science Based Targets initiative (SBTi) and the RE100 programme, which aim to enhance sustainability and reduce carbon footprints across their operations. As a subsidiary, Pharmavite's climate actions are likely informed by the performance and targets established by Otsuka Holdings, which operates at a cascade level of 2 in this context. This relationship underscores the importance of corporate family dynamics in shaping individual company commitments to climate action. In summary, while Pharmavite LLC does not currently report specific emissions data or reduction targets, it is part of a larger corporate structure that prioritises sustainability and climate responsibility through initiatives led by Otsuka Holdings.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 101,000,000 | - | - | - | - | 000,000,000 | - | - |
| Scope 2 | 159,000,000 | - | - | - | - | 0,000,000 | - | - |
| Scope 3 | 866,000,000 | - | - | - | 000,000,000 | - | - | - |
How Carbon Intensive is Pharmavite LLC's Industry?
How Carbon Intensive is Pharmavite LLC's Location?
Pharmavite LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmavite LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
